Cart (Loading....) | Create Account
Close category search window
 

In Vivo Brain Magnetic Resonance Spectroscopy: A Measurement of Biomarker Sensitivity to Post-Processing Algorithms

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

The purchase and pricing options are temporarily unavailable. Please try again later.
5 Author(s)
Cocuzzo, D. ; Dept. of Comput. Sci., Stanford Univ., Palo Alto, CA, USA ; Lin, A. ; Stanwell, P. ; Mountford, C.
more authors

Clinical translation of reported biomarkers requires reliable and consistent algorithms to derive biomarkers. However, the literature reports statistically significant differences between 1-D MRS measurements from control groups and subjects with disease states but frequently provides little information on the algorithms and parameters used to process the data. The sensitivity of in vivo brain magnetic resonance spectroscopy biomarkers is investigated with respect to parameter values for two key stages of post-acquisitional processing. Our effort is specifically motivated by the lack of consensus on approaches and parameter values for the two critical operations, water resonance removal, and baseline correction. The different stages of data processing also introduce varying levels of uncertainty and arbitrary selection of parameter values can significantly underutilize the intrinsic differences between two classes of signals. The sensitivity of biomarkers points to the need for a better understanding of how all stages of post-acquisitional processing affect biomarker discovery and ultimately, clinical translation. Our results also highlight the possibility of optimizing biomarker discovery by the careful selection of parameters that best reveal class differences. Using previously reported data and biomarkers, our results demonstrate that small changes in parameter values affect the statistical significance and corresponding effect size of biomarkers. Consequently, it is possible to increase the strength of biomarkers by selecting optimal parameter values in different spectral intervals. Our analyses with a previously reported data set demonstrate an increase in effect sizes for wavelet-based biomarkers of up to 36%, with increases in classification performance of up to 12%.

MR brain spectroscopy biomarkers are diagnostic for a wide variety of neurological disorders. We quantify the sensitivity of prospective biomarkers for spinal cord injury to changes in specific parameter values. Our results demonstrate that the statistical significance of candidate biomarkers can change dramatically with slight changes in individual parameters and identifying parameter values that maximize statistical significance and effect size can improve the diagnostic power of prospective biomarkers. MR brain spectroscopy biomarkers are diagnostic for a wide variety of neurological disorders. We quantify the sensitivity of prospective biomarkers for spinal cord injury to changes in specific parameter values. Our results demonstrate that the statistical significance of candidate biomarkers can change dramatically with slight changes in individual parameters and identifying parameter values that maximize statistical significance and effect size can improve the diagnostic power of prospective biomarkers.

Published in:

Translational Engineering in Health and Medicine, IEEE Journal of  (Volume:2 )

Date of Publication:

2014

Need Help?


IEEE Advancing Technology for Humanity About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2014 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.